GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » Debt-to-EBITDA

M1 Kliniken AG (XTER:M12) Debt-to-EBITDA : 0.65 (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

M1 Kliniken AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €4.3 Mil. M1 Kliniken AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €8.9 Mil. M1 Kliniken AG's annualized EBITDA for the quarter that ended in Jun. 2023 was €20.3 Mil. M1 Kliniken AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was 0.65.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for M1 Kliniken AG's Debt-to-EBITDA or its related term are showing as below:

XTER:M12' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0.56   Max: 0.86
Current: 0.66

During the past 9 years, the highest Debt-to-EBITDA Ratio of M1 Kliniken AG was 0.86. The lowest was 0.00. And the median was 0.56.

XTER:M12's Debt-to-EBITDA is ranked better than
76.48% of 421 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs XTER:M12: 0.66

M1 Kliniken AG Debt-to-EBITDA Historical Data

The historical data trend for M1 Kliniken AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG Debt-to-EBITDA Chart

M1 Kliniken AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only - 0.69 0.86 0.56 0.80

M1 Kliniken AG Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.61 0.76 0.70 0.65

Competitive Comparison of M1 Kliniken AG's Debt-to-EBITDA

For the Medical Care Facilities subindustry, M1 Kliniken AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M1 Kliniken AG's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M1 Kliniken AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's Debt-to-EBITDA falls into.



M1 Kliniken AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

M1 Kliniken AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.377 + 10.324) / 17.124
=0.80

M1 Kliniken AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.26 + 8.851) / 20.324
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.


M1 Kliniken AG  (XTER:M12) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


M1 Kliniken AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


M1 Kliniken AG (XTER:M12) Business Description

Traded in Other Exchanges
Address
Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Executives
Kilian Brenske Board of Directors
Attila Strauss Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines